The 3-BP mediated inhibition of glycolysis occurs mainly through targeting hexokinase-II (HK-II) and GAPD, which allows 3-BP to decrease the production of ATP, induce apoptosis, increase ROS and consequently cause growth inhibition in cancer cells including ovarian cancer [43]. The gene discussed is GAPDH; the disease is ovarian cancer.